ANXA2 and hepatocellular carcinoma: ANXA2 promotes cell invasion in malignancies of the breast, brain, liver, and pancreas [10–12, 36, 37] and enhances cell motility and cell adhesion of prostate and hepatocellular carcinoma cells [38, 39].